CD19 and hepatocellular carcinoma: In addition, an increase in the frequency of CD19-B220+CD5+CD1d- B cells, although not significant, was detected in the livers of the mice with MASLD (Fig. S2D) and HCC/NRASG12/p19Arf-/- (Fig. S2P).